122 related articles for article (PubMed ID: 38075378)
1. Retracted: C-myc/TSPEAR-AS2 Axis Facilitates Breast Cancer Growth and Metastasis in a GLUT1-Dependent Glycolysis Manner.
International BR
Biomed Res Int; 2023; 2023():9823789. PubMed ID: 38075378
[TBL] [Abstract][Full Text] [Related]
2. C-myc/TSPEAR-AS2 Axis Facilitates Breast Cancer Growth and Metastasis in a GLUT1-Dependent Glycolysis Manner.
Xu J; Li T; Zhang Y; Qiu D; Chen N; Chai X; PengLi ; Li J
Biomed Res Int; 2022; 2022():4239500. PubMed ID: 35692593
[TBL] [Abstract][Full Text] [Related]
3. BTEB2-Activated lncRNA TSPEAR-AS2 Drives GC Progression through Suppressing GJA1 Expression and Upregulating CLDN4 Expression.
Ma ZH; Shuai Y; Gao XY; Yan Y; Wang KM; Wen XZ; Ji JF
Mol Ther Nucleic Acids; 2020 Dec; 22():1129-1141. PubMed ID: 33294297
[TBL] [Abstract][Full Text] [Related]
4. lncRNA TSPEAR-AS2, a Novel Prognostic Biomarker, Promotes Oral Squamous Cell Carcinoma Progression by Upregulating PPM1A via Sponging miR-487a-3p.
Xia YC; Cao J; Yang J; Zhang Y; Li YS
Dis Markers; 2021; 2021():2217663. PubMed ID: 34336002
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA TSPEAR Antisense RNA 2 is downregulated in rheumatoid arthritis and inhibits the apoptosis of fibroblast-like synoviocytes by downregulating microRNA-212-3p (miR-212-3p).
Lv Z; Ye S; Wang Z; Xin P; Chen Y; Tan Z; Zhuang Y
Bioengineered; 2022 Feb; 13(2):4166-4172. PubMed ID: 35112979
[TBL] [Abstract][Full Text] [Related]
6. METTL3-induced DLGAP1-AS2 promotes non-small cell lung cancer tumorigenesis through m
Zhang Q; Zhang Y; Chen H; Sun LN; Zhang B; Yue DS; Wang CL; Zhang ZF
Cell Cycle; 2022 Dec; 21(24):2602-2614. PubMed ID: 35972892
[TBL] [Abstract][Full Text] [Related]
7. Diclofenac impairs the proliferation and glucose metabolism of triple-negative breast cancer cells by targeting the c-Myc pathway.
Yang L; Li J; Li Y; Zhou Y; Wang Z; Zhang D; Liu J; Zhang X
Exp Ther Med; 2021 Jun; 21(6):584. PubMed ID: 33850556
[TBL] [Abstract][Full Text] [Related]
8. Transcription factor c-Jun modulates GLUT1 in glycolysis and breast cancer metastasis.
Zhu P; Liu G; Wang X; Lu J; Zhou Y; Chen S; Gao Y; Wang C; Yu J; Sun Y; Zhou P
BMC Cancer; 2022 Dec; 22(1):1283. PubMed ID: 36476606
[TBL] [Abstract][Full Text] [Related]
9. Retraction statement: Ding, J., Wang, X., Gao, J. and Song, T. (2021), Silencing of cystatin SN abrogates cancer progression and stem cell properties in papillary thyroid carcinoma. FEBS Open Bio, 11: 2186-2197.
FEBS Open Bio; 2023 Aug; 13(8):1540. PubMed ID: 37410095
[TBL] [Abstract][Full Text] [Related]
10. [Retracted] miR‑143‑5p suppresses breast cancer progression by targeting the HIF‑1α‑related GLUT1 pathway.
Xu J; Li X; Zhang P; Luo J; Mou E; Liu S
Oncol Lett; 2024 Jul; 28(1):311. PubMed ID: 38784604
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA FGF14-AS2 inhibits breast cancer metastasis by regulating the miR-370-3p/FGF14 axis.
Jin Y; Zhang M; Duan R; Yang J; Yang Y; Wang J; Jiang C; Yao B; Li L; Yuan H; Zha X; Ma C
Cell Death Discov; 2020; 6():103. PubMed ID: 33083023
[TBL] [Abstract][Full Text] [Related]
12. RETRACTED: Down-regulation of lncRNA ADAMTS9-AS2 contributes to gastric cancer development via activation of PI3K/Akt pathway.
Cao B; Liu C; Yang G
Biomed Pharmacother; 2018 Nov; 107():185-193. PubMed ID: 30089248
[TBL] [Abstract][Full Text] [Related]
13. Retracted: Sevoflurane Inhibits lncRNA HOTAIR-Modulated Stability of HK2 mRNA in a m6A-Dependent Manner to Dampen Aerobic Glycolysis and Proliferation in Lung Cancer.
International BR
Biomed Res Int; 2023; 2023():9805840. PubMed ID: 38075331
[TBL] [Abstract][Full Text] [Related]
14. Shikonin regulates C-MYC and GLUT1 expression through the MST1-YAP1-TEAD1 axis.
Vališ K; Talacko P; Grobárová V; Černý J; Novák P
Exp Cell Res; 2016 Dec; 349(2):273-281. PubMed ID: 27793648
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA HIF1A-As2 and MYC form a double-positive feedback loop to promote cell proliferation and metastasis in KRAS-driven non-small cell lung cancer.
Yang K; Zhang W; Zhong L; Xiao Y; Sahoo S; Fassan M; Zeng K; Magee P; Garofalo M; Shi L
Cell Death Differ; 2023 Jun; 30(6):1533-1549. PubMed ID: 37041291
[TBL] [Abstract][Full Text] [Related]
16. DLGAP1-AS2 promotes human colorectal cancer progression through trans-activation of Myc.
Ren C; Han H; Pan J; Chang Q; Wang W; Guo X; Bian J
Mamm Genome; 2022 Dec; 33(4):672-683. PubMed ID: 36222892
[TBL] [Abstract][Full Text] [Related]
17. Circular RNA circDENND4C facilitates proliferation, migration and glycolysis of colorectal cancer cells through miR-760/GLUT1 axis.
Zhang ZJ; Zhang YH; Qin XJ; Wang YX; Fu J
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2387-2400. PubMed ID: 32196590
[TBL] [Abstract][Full Text] [Related]
18. Retracted: Knockdown of lncRNA
And Alternative Medicine EC
Evid Based Complement Alternat Med; 2023; 2023():9859158. PubMed ID: 37501828
[TBL] [Abstract][Full Text] [Related]
19. The c-Myc-LDHA axis positively regulates aerobic glycolysis and promotes tumor progression in pancreatic cancer.
He TL; Zhang YJ; Jiang H; Li XH; Zhu H; Zheng KL
Med Oncol; 2015 Jul; 32(7):187. PubMed ID: 26021472
[TBL] [Abstract][Full Text] [Related]
20. Dihydroartemisinin and artesunate inhibit aerobic glycolysis via suppressing c-Myc signaling in non-small cell lung cancer.
Zhang Y; Wang Y; Li Y; Huang C; Xiao X; Zhong Z; Tang J; Lu H; Tang Y; Yang J
Biochem Pharmacol; 2022 Apr; 198():114941. PubMed ID: 35149053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
